We’re excited to see you in Indianapolis!

Our mission is to help you personalize diagnosis and treatment for your patients with thyroid nodules. Stop by booth #909 to learn how Veracyte is using whole-transcriptome-derived analysis on every sample to provide an actionable Afirma GSC report and create the potential for novel research.  

Data being presented during the conference:  

Development of Novel mRNA Classifiers to Stratify Preoperative Thyroid Tumor Risk

Sunday, October 12^th

1:42 – 1:48 PM EDT (“Best of Scientific Orals”) (Location:120)

2:30 – 2:36 PM EDT (Location: 128)

Presented by Thomas F. Barrett, MD, Jr.  (Washington University – St Louis)

The Molecular Heterogeneity of NRAS Variants in Thyroid Nodules

Sunday, October 12^th

2:36 – 2:42 PM EDT (Location: 128)

Presented by Emma R. De Ravin, MD (Thomas Jefferson University)